AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Omizra ES 40mg Tablet

Prescription Icon
Prescription Required

Marketer

Astrica Biomedics Pvt Ltd

Salt Composition

Esomeprazole (40mg)

Overview Omizra ES 40mg Tablet

Gastro-Gard 40mg tablets effectively manage conditions stemming from excessive stomach acid, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. This medication diminishes gastric acid production, alleviating symptoms and facilitating healing. Gastro-Gard 40mg tablets also prevent stomach ulcers induced by certain drugs, like NSAIDs. Dosage, determined by your physician, should be the minimal effective amount for the shortest necessary duration. Administer on an empty stomach, ideally mornings or at least an hour before meals. Continue treatment as prescribed, even after symptom resolution. Long-term use necessitates regular magnesium level monitoring, as this medication can deplete magnesium. Headache, constipation, diarrhea, abdominal pain, and nausea are potential side effects; though usually mild, report persistent or bothersome symptoms. Prolonged use elevates the risk of side effects, including increased bone fracture risk. Minimize trigger foods (rich, spicy, fatty meals) and beverages (caffeinated drinks, alcohol) to optimize treatment. Consult your doctor before use if you have severe liver disease, are on HIV medication, have prior allergic reactions to similar drugs, or suffer from osteoporosis. While alcohol doesn't directly impact Gastro-Gard's efficacy, it increases stomach acid production. Dizziness, drowsiness, or visual disturbances are possible; avoid driving, cycling, or operating machinery if affected. Use during pregnancy and breastfeeding is generally discouraged.

Uses of Omizra ES 40mg Tablet

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Omizra ES 40mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Omizra ES 40mg Tablet on an empty stomach.

Common Side effects of Omizra ES 40mg Tablet:

  • Headache
  • Dryness in mouth
  • Nausea
  • Abdominal pain
  • Constipation
  • Flatulence
  • Diarrhea

How to use Omizra ES 40mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Omizra ES 40mg Tablet on an empty stomach.

How Omizra ES 40mg Tablet works:

Esomeprazole 40mg tablets, a proton pump inhibitor, decrease stomach acid production, providing relief from heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Omizra ES 40mg Tablet and alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Omizra ES 40mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Omizra ES 40mg Tablet use while breastfeeding is lacking. Consult your physician for guidance. Breastfeeding mothers should use this medication with care.

DrivingDrivingUNSAFE

Driving ability may be impaired by Omizra ES 40mg Tablet side effects. Infrequently, dizziness or blurred vision may occur; refrain from operating vehicles or machinery if these symptoms arise.

KidneyKidneySAFE IF PRESCRIBED

Omizra ES 40mg tablets are considered safe for use in individuals with kidney disease, and no dosage modification is necessary. Nevertheless, patients exhibiting severe renal impairment should be monitored closely due to insufficient clinical data.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Omizra ES 40mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Dosage alteration is unnecessary for individuals with mild or moderate liver dysfunction.

What if you forget to take Omizra ES 40mg Tablet :

Should you forget to take your Omizra ES 40mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Omizra ES 40mg Tablet

LabelValue
Pharmacological Category Benzimidazole sulfone
Potential for Dependence None.
Medication Classification Gastrointestinal tract
Mechanism of Action Gastric acid secretion suppressants

FAQs on Omizra ES 40mg Tablet

Omizra ES 40mg tablets are typically administered once daily, upon waking. For twice-daily regimens, divide the dose evenly between morning and evening. Ingest the tablets whole—do not crush or chew—at least an hour before food, with water.
The concomitant use of Omizra ES 40mg Tablet and domperidone is considered safe, with no documented adverse interactions. A combined formulation of these medications also exists. Omizra ES 40mg Tablet reduces stomach acid, while domperidone enhances gastrointestinal motility. This synergistic effect proves highly beneficial in managing reflux esophagitis, heartburn, and peptic ulcers.
Concurrent use of antacids and Omizra ES 40mg tablets is permissible, provided there's a two-hour interval between administrations.
The 40mg Omizra ES tablet is typically intended for short-term treatment. Nevertheless, its use may extend to longer periods under medical supervision, particularly in managing peptic ulcers or Zollinger-Ellison syndrome (ZES). Prolonged treatment increases the potential for adverse reactions; therefore, extended use necessitates discussion with a physician. Always follow your doctor's instructions when taking Omizra ES 40mg tablets.
Extended Omizra ES 40mg Tablet use beyond three months can trigger several long-term adverse reactions. Hypomagnesemia, characterized by fatigue, disorientation, dizziness, tremors, and vertigo, is a primary concern. Muscle spasms and cardiac arrhythmias are also possible. Prolonged use exceeding one year elevates the risk of bone fractures, gastrointestinal infections, and vitamin B12 deficiency. This deficiency may cause anemia, manifesting as increased fatigue, weakness, pallor, palpitations, dyspnea, lightheadedness, dyspepsia, anorexia, flatulence, and neurological symptoms including paresthesia and gait disturbances.
Prolonged use of Omizra ES 40mg Tablets necessitates a gradual discontinuation. Sudden cessation may heighten stomach acid levels, potentially exacerbating your condition. Consult your physician before adjusting your dosage or discontinuing this medication.
An increase in body weight has been observed in fewer than 1% of individuals using Omizra ES 40mg Tablet; however, the underlying mechanism remains unclear. A potential contributing factor is increased caloric consumption following the alleviation of reflux symptoms. Adopting healthy lifestyle choices, including balanced nutrition and regular physical activity, may mitigate weight gain.
Omizra ES 40mg Tablets generally have a good safety profile. The majority of users experience no adverse effects. For optimal results, follow your physician's prescribed dosage.
Omizra ES 40mg Tablets may be co-administered with ranitidine; studies indicate no substantial drug interactions. Nevertheless, concurrent use should only occur under medical supervision.
Consumption of alcohol is not recommended while taking Omizra ES 40mg Tablets. While alcohol doesn't directly interfere with the medication's mechanism, it can elevate stomach acid levels, potentially exacerbating existing symptoms.
Omizra ES 40mg Tablet
62
MRP 75
17% off